Dracen Pharmaceuticals Funding: $40M Raised, Series A (2018)
Dracen Pharmaceuticals is based in Baltimore. It has raised $40M in total funding. Latest round: Series A.
Dracen Pharmaceuticals funding overview
Dracen Pharmaceuticals is based in Baltimore. Dracen Pharmaceuticals has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2018. The round record for Dracen Pharmaceuticals runs through 2018; nothing later has been disclosed. Investors on record include Deerfield Management, Osage University Partners, i&i Prague. 3 distinct backers are named across the disclosed rounds.
Dracen Pharmaceuticals at a glance
Total raised
$40M
Latest round
Series A
Latest round date
March 2018
Headquarters
Baltimore
Notable investors
Deerfield Management, Osage University Partners, i&i Prague
Frequently asked about Dracen Pharmaceuticals funding
How much has Dracen Pharmaceuticals raised?
Dracen Pharmaceuticals has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Dracen Pharmaceuticals?
Deerfield Management, Osage University Partners, i&i Prague are named among the investors backing Dracen Pharmaceuticals.
What was the latest Dracen Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in March 2018.
Where is Dracen Pharmaceuticals based?
Dracen Pharmaceuticals is based in Baltimore.
When did Dracen Pharmaceuticals last raise?
The last disclosed Dracen Pharmaceuticals round closed in March 2018 at Series A.
Dracen Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Baltimore below to benchmark round size and investor mix.
